Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all
Page 1
Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy.
Heaton KM, Ju G, Grimm EA. Heaton KM, et al. Cancer Res. 1993 Jun 1;53(11):2597-602. Cancer Res. 1993. PMID: 8495422 Free article.
Induction of lymphokine-activated killing with reduced secretion of interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma by interleukin-2 analogs.
Heaton KM, Ju G, Grimm EA. Heaton KM, et al. Ann Surg Oncol. 1994 May;1(3):198-203. doi: 10.1007/BF02303524. Ann Surg Oncol. 1994. PMID: 7842289
Feedback